The invention relates to an oral tiopronin composition for reducing the dosing frequency in treatment of cysteinuria comprising of therapeutically effective amount of tiopronin and one or more pharmaceutically acceptable excipients.

The Invention relates to an oral pencillamine composition for reducing the dosing frequency in treatment of cysteinuria comprising of therapeutically effective amount of pencillamine and one or more pharmaceutically acceptable excipients.

The invention relates to a room temperature storage stable trientine composition comprising of pharmaceutically acceptable solid oral dosage form of trientine; and oxidation resistant container system. The invention also relates to a method of storing trientine solid oral composition at room temperature without deg...

A stable multi dose tiopronin oral solution formulation with enhanced bioavailability, for the treatment of cystinuria and also for the treatment of Wilsons disease. The multi-dose tiopronin oral solution comprising of therapeutically effective tiopronin or a pharmaceutically acceptable salt thereof, at least one ve...

A multi dose fludrocortisone oral solution formulation for administration in neonates and infants for the treatment of primary and secondary adrenocortical insufficiency in Addison’s disease and for the treatment of salt-losing adrenogenital syndrome. The multi-dose fludrocortisone oral solution comprising of fludro...